# Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock

> **NCT04948372** · NA · COMPLETED · sponsor: **Southeast University, China** · enrollment: 22 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Terlipressin treatment
- **DRUG:** Usual care

## Key facts

- **NCT ID:** NCT04948372
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-01
- **Primary completion:** 2020-05-31
- **Final completion:** 2020-06-28
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2021-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04948372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04948372, "Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04948372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*